ClinicalTrials.gov
public full text
Public Domain
Preoperative Bevacizumab for Vitreous Hemorrhage
The purpose of this study is to determine whether preoperative intravitreal bevacizumab is effective in reducing intra-operative and postoperative bleeding in diabetic patients submitted to pars plana vitrectomy for vitreous hemorrhage.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Pre- and Intra-operative Intravitreal Bevacizumab Injection in Diabetic Vitrectomy#1075016
- Preoperative Intravitreal Ranibizumab for Persistent Diabetic Vitreous Haemorrhage:#442051
- Carbetocin Versus Oxytocin for Prophylaxis Against Atonic Primary Post-partum Hemorrhage#806216
- Intravitreal Ozurdex After Pars Plana Vitrectomy for Proliferative Diabetic Retinopathy#828098
- Factor VIIa in Acute Intracerebral Haemorrhage#804488
Record · ID 825017
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive